Cullinan Oncology, Inc. is a American stock, trading under the symbol CGEM-Q on the NASDAQ (CGEM). It is usually referred to as NASDAQ:CGEM or CGEM-Q
In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.
Cullinan Oncology, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cullinan Oncology, Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.
On 2023-06-02, Cullinan Oncology, Inc. (CGEM-Q) stock closed at a price of $10.53.
CGEM is a unique pharmaceutical company that collaborates with other developers and academia to develop drugs to help cancer patients. It has six on-going products in its pipeline. It trades below book value, at 6x earnings, and supports a 19% ROE. We like that it is low beta compared to the market. We recommend a stop-loss at $8.50, looking to achieve $17 — upside potential of 50%. Yield 0%
(Analysts’ price target is $28.75)